龙胆泻肝汤辅助治疗边缘性角膜炎疗效观察

发布时间：2019-05-27 04:01

【摘要】：目的:观察龙胆泻肝汤辅助治疗边缘性角膜炎的临床疗效及复发情况。方法:将29例32眼肝胆湿热型边缘性角膜炎患者随机分为2组,对照组14例14眼,予常规局部抗炎治疗;治疗组15例18眼,在对照组治疗的基础上加用龙胆泻肝汤辅助治疗,疗程为1周,随访1月,观察2组临床疗效及复发情况。结果:治愈率、愈显率治疗组分别为72.22%、94.44%,对照组分别为14.29%、78.57%。2组临床疗效比较,经Fisher精确概率法检验,差异有统计学意义(P0.05)。治疗组患者口干口苦、咽喉肿痛症状好转率高于对照组(P0.05),失眠、便秘好转率2组差异无统计学意义(P0.05)。随访1月,愈显率、复发率治疗组分别为100%、5.56%,对照组分别为85.71%、11.11%,2组比较,差异均无统计学意义(P0.05)。结论:龙胆泻肝汤辅助治疗边缘性角膜炎近期疗效肯定。
[Abstract]:Objective: to observe the clinical effect and recurrence of Longdan Xiegan decoction in the treatment of marginal keratitis. Methods: 29 patients (32 eyes) with hepatobiliary dampness-heat marginal keratitis were randomly divided into two groups: control group (14 eyes) and control group (14 eyes). 18 eyes of 15 patients in the treatment group were treated with Longdan Xiegan decoction on the basis of treatment in the control group. The course of treatment was 1 week and followed up for 1 month. The clinical efficacy and recurrence of the two groups were observed. Results: the cure rate and the more obvious rate were 72.22% and 94.44% in the treatment group and 14.29% in the control group, and 78.57% .2 in the control group. The difference was statistically significant by Fisher exact probability method (P 0.05). The improvement rate of dry mouth and sore throat in the treatment group was higher than that in the control group (P 0.05). There was no significant difference in the improvement rate of insomnia and defecation between the two groups (P 0.05). After 1 month follow-up, the recurrence rate was 100%, 5.56% in the treatment group and 85.71% and 11.11% in the control group, respectively. There was no significant difference between the two groups (P 0.05). Conclusion: Longdan Xiegan decoction is effective in the treatment of marginal keratitis in the near future.
【作者单位】：广州中医药大学第一附属医院眼科;
【分类号】：R772.21

【相似文献】